Prestige Consumer Healthcare Inc. (PBH)
Pre-market:
| Previous close | 70.00 |
| Open | 70.08 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 69.92 - 70.76 |
| 52-week range | 52.90 - 75.31 |
| Volume | |
| Avg. volume | 228,936 |
| Market cap | 3.472B |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.61 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Dec 2013 |
| 1y target est | 75.60 |
ZacksPrestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GlobeNewswirePrestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tuesday, May 14, 2024 after the market close. The Company will host a conference call to discuss the results the following morning, May 15th, at 8:30 a.m. ET. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.pre
ZacksHere's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
